Live tape
Top 8, mentions 7d9,472TSLA1,996 mentions▲ +0.05GOOGL1,538 mentions▲ +0.05NVDA1,158 mentions▲ +0.07CRWV1,139 mentions▲ +0.03SPCX1,031 mentions▲ +0.07QQQ1,002 mentions▲ +0.04META808 mentions▲ +0.05NBIS800 mentions▲ +0.05

Equity · Healthcare

BEAM

NASDAQ

Beam Therapeutics Inc.

$23.49 −5.03% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026
Price · Chart
63 sessions
$32.5 $22.5 21 Jul 16 Oct

The line runs $27.28 on 21 July through $23.49 on 16 October, on a scale from $22.5 to $32.5. Days the market did not trade hold the previous close, flat.

Market cap $2.4B
52-week range $20.60 – $37.96
Avg volume 100.6K

as of Oct 16, 2026

BEAM insider trades

SEC Form 4

BEAM has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 27 October 2025.

Date Insider Type Shares Value
27 Oct 2025 FMR LLC Sell 459 $12K
02 Oct 2025 Evans John M. CEO Sell 25,000 $616K
01 Oct 2025 Evans John M. CEO Sell 25,000 $613K
01 Oct 2025 Bellon Christine Chief Legal Officer Sell 373 $9K
01 Oct 2025 Cavanagh Bethany J SVP, Finance and Treasurer Sell 467 $11K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
06 Oct 2025 FMR LLC Gift 1,232,434
02 Oct 2025 Evans John M. CEO Option exercise 25,000 $17K
01 Oct 2025 Evans John M. CEO Option exercise 25,000 $17K

BEAM reported financials

SEC EDGAR XBRL SEC EDGAR

BEAM reported revenue of $139.7M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$80.0M.

Figure Reported Period
Revenue $139.7M 31 Dec 2025 fiscal year
Net income −$80.0M 31 Dec 2025 fiscal year
Diluted EPS −$0.81 31 Dec 2025 fiscal year
Total assets $1.4B 30 Jun 2026 at period end
Total equity $1.1B 30 Jun 2026 at period end

BEAM earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$1.18 —
31 Mar 2026 Q1 2026 −$0.91 —
31 Dec 2025 FY 2025 −$0.81 —
30 Sep 2025 Q3 2025 −$1.10 —
30 Jun 2025 Q2 2025 −$1.00 —
31 Mar 2025 Q1 2025 −$1.23 —
31 Dec 2024 FY 2024 −$4.58 —
30 Sep 2024 Q3 2024 −$1.17 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BEAM institutional holders

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a BEAM position for the quarter ended 30 Jun 2026 — a combined $449.8M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
ARK Investment Management Held (±25%) −15.6% shares 10,234,862 $351.3M
Two Sigma Investments Held (±25%) +14.6% shares 1,388,227 $47.6M
Marshall Wace Added +244.0% shares 478,980 $16.4M
Renaissance Technologies Held (±25%) −13.4% shares 445,000 $15.3M
Duquesne Family Office New position 153,600 $5.3M
D. E. Shaw & Co. New position 130,577 $4.5M
Man Group Trimmed −44.0% shares 129,820 $4.5M
Tudor Investment Corp Held (±25%) +3.8% shares 49,092 $1.7M
Balyasny Asset Management New position 41,792 $1.4M
Millennium Management Added +54.1% shares 34,260 $1.2M

Showing the 10 largest of 11 reported positions. The figures above count all of them.

BEAM fails-to-deliver

SEC CNS data SEC

On 28 Sep 2026, 1,512 shares of BEAM failed to deliver (about $37K).

Settlement date Shares failed Notional % of shares out
28 Sep 2026 1,512 $37K 0.001%
21 Sep 2026 51,006 $1.3M 0.049%
16 Sep 2026 215 $5K <0.001%
15 Sep 2026 826 $20K 0.001%
04 Sep 2026 2,930 $86K 0.003%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings